Related Experiment Video
Updated: Oct 3, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
The Platelia Aspergillus ELISA in diagnosis of invasive pulmonary aspergilosis (IPA)
1Pathologisch-Bakteriologisches Institut, Städtisches Krankrenhaus, Kiel, Germany.
Abstract:
The sensitivity of a sandwich enzyme-linked immunosorbent assay (ELISA) for detecting Aspergillus galactomannan was evaluated with 66 serum samples and 113 specimens of the respiratory tract obtained from 52 patients with pulmonary diseases. The patients were divided into five groups: proven invasive pulmonary aspergillosis (IPA) (five patients), probable IPA (seven patients), Aspergillus colonization (eight patients) or unlikely Aspergillus infection (27 patients). Another five patients with doubtful diagnostic test results are discussed in detail. The results of the Platelia Aspergillus ELISA (Sanofi Pasteur, Freiburg, Germany) in testing specimens of the respiratory tract were 90% sensitivity in proven (serum 38%), 60% in probable (serum 37%) and 71% in Aspergillus colonization (serum 0%). Furthermore, 85% of the Aspergillus spp. from positive cultures of specimens of the respiratory tract were also detected in the ELISA. A total of 57% of the culture negative specimens of patients with a least one positive culture or proven aspergillosis in a series of specimens were positive in the ELISA.
Insights
This study evaluated the Aspergillus galactomannan enzyme-linked immunosorbent assay (ELISA) for diagnosing pulmonary aspergillosis. The ELISA showed promising sensitivity, especially in respiratory tract specimens, aiding in early detection of invasive fungal infections.
Area of Science:
- Medical diagnostics
- Clinical microbiology
- Mycology
Background:
- Pulmonary aspergillosis is a serious fungal infection, often difficult to diagnose.
- Early and accurate detection is crucial for effective patient management.
- The Aspergillus galactomannan antigen test is a valuable tool in diagnosing invasive aspergillosis.
Observation:
- This study assessed the sensitivity of a sandwich enzyme-linked immunosorbent assay (ELISA) for detecting Aspergillus galactomannan.
- Specimens included serum and respiratory tract samples from patients with various pulmonary diseases.
- Patient groups comprised proven, probable, and unlikely invasive pulmonary aspergillosis, as well as Aspergillus colonization.
Findings:
- The Platelia Aspergillus ELISA demonstrated high sensitivity in respiratory tract specimens (90% for proven IPA, 60% for probable IPA, 71% for colonization).
- Serum sensitivity was lower (38% for proven IPA, 37% for probable IPA, 0% for colonization).
- The ELISA detected 85% of Aspergillus species from positive respiratory cultures and 57% of culture-negative specimens from patients with proven aspergillosis or positive cultures.
Implications:
- The Aspergillus galactomannan ELISA, particularly using respiratory tract specimens, can significantly improve the diagnosis of pulmonary aspergillosis.
- This diagnostic tool aids in differentiating invasive aspergillosis from colonization and in managing patients with suspected fungal infections.
- Further research may optimize the use of ELISA in conjunction with other diagnostic methods for comprehensive Aspergillus infection assessment.
Related Concept Videos
Enzyme-Linked Immunosorbent Assay
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Fungal Phylum Ascomycota
Atypical Pneumonia